• News & Media
  • Careers
  • Contact Us
  • ""
  • Home
  • About Us
  • BUSINESSES
  • Foundation
  • Investors
    News & Media Careers Contact Us
    • Home
    • About Us
      • Who We Are
      • Our Values
      • Our History
      • Board of Directors
      • Management Team
    • Business
      • Piramal Enterprises Ltd.
      • Piramal Pharma Ltd.
      • Piramal Realty
    • Foundation
    • investor
      • Piramal Enterprises Ltd
      • Piramal Pharma Ltd
    • Privacy Policy
    • Disclaimer
    • © 2022 Piramal Enterprises Ltd.
    1. Investors
    2. Piramal Enterprises Limited
    3. Shareholder Information
    4. Composite Scheme of Arrangement

    Composite Scheme of Arrangement

    • Shareholding
      Pattern
    • Notice
    • Share
      Capital
    • Dividend
    • Unclaimed
      Dividend
    • Credit
      Rating
    • PPMLD
      Valuation
    • Forms
    • Announcements
    • Statement of
      Employees
    • ESOP
      Disclosure
    • Scheme of
      Amalgamation
    • Composite Scheme
      of Arrangement
    • Rights
      Issue
    • Postal
      Ballot
    • Buyback
      2023
    • NCD Public
      Issuance 2023
    • Online Dispute Resolution (ODR)
    • Cost of Acquisition of PEL and PPL shares

    • PEL – Newspaper advertisement for Notice of Record Date

    • Final Composite Scheme of Arrangement

    • PEL – Intimation of Record Date for ascertaining the Shareholders entitled to receive equity shares of PPL in accordance with the Scheme

    • NCLT Final Order dated 12th August, 2022

    • Newspaper Advertisement for Notice of Hearing of Petition – 23rd July, 2022

    • NCLT Order dated July 19, 2022

    • PEL – Transcript of NCLT Convened Meeting of Equity Shareholders on 5th July, 2022

    • Voting Results and Consolidated Scrutinizer’s Report of NCLT convened meeting of Equity Shareholders – 5th July, 2022

    • Scrutinizer’s Report of NCLT convened meeting of Secured & Unsecured Creditors – 5th July, 2022

    • PEL – Proceedings of NCLT Convened Meeting of Equity Shareholders – 5th July, 2022

    • PEL – Proceedings of NCLT Convened Meeting of Secured Creditors – 5th July, 2022

    • PEL – Proceedings of NCLT Convened Meeting of Unsecured Creditors – 5th July, 2022

    • Newspaper advertisement for Corrigendum Order of Rectification – 16th June, 2022

    • Newspaper advertisement for NCLT convened meetings – 4th June, 2022

    • Due Diligence Certificates on Abridged Prospectus

    • NCLT Corrigendum Order of Rectification dated June 3, 2022

    • NCLT Notice – Equity Shareholders

    • NCLT Notice – Secured Creditors

    • NCLT Notice – Unsecured Creditors

    • Composite Scheme of Arrangement

    • Valuation Report

    • Audit Committee Report

    • Fairness Opinion

    • Pre and Post Shareholding Pattern

    • Audited Financials of last 3 years of the unlisted entities

    • Accounting treatment certificate

    • Compliance Report

    • Independent Directors Report

    • Final Observation Letter – BSE

    • Final Observation Letter – NSE

    • Response to Observation Letter – BSE

    • Response to Observation Letter – NSE

    • NCLT Order dated May 12, 2022

    Investor Presentation

    • PEL Investor Presentation – Q4 FY2023

    Download

    Quick Links

    • Annual Report – 2022-23
    • Investor Calls
    • Buyback – 2023
    • Investor Contacts
    • Press Releases
    • In The News
    Piramal Group
    • Piramal Enterprises Ltd.(PEL)
    • Piramal Pharma Ltd.(PPL)
    • Piramal Realty
    • Piramal Foundation
    Piramal Enterprises Ltd.
    • Financial Services
    • – Piramal Capital & Housing Finance Limited   (PCHFL)
    • – Piramal Alternatives (PA)
      • India Access Fund of Funds
      • Growth Capital Fund
      • Performing Credit Fund (PCF)
      • India Resurgence Fund (IndiaRF)
    Piramal Pharma Ltd.
    • Piramal Pharma Ltd.
    • – Pharma Solutions
    • – Critical Care
    • – Consumer Products
    • – Allergan India Private Limited
    Piramal Realty
    • – Piramal Mahalaxmi
    • – Piramal Aranya
    • – Piramal Revanta
    • – Piramal Vaikunth
    • – Piramal Agastya

    © 2024 Piramal Enterprises Ltd.

    • Privacy Policy
    • Disclaimer